Both phospholipase (PL) C-␥1 and Akt (protein kinase B; PKB) are signaling proteins that play significant roles in the intracellular signaling mechanism used by receptor tyrosine kinases, including epidermal growth factor (EGF) receptor (EGFR). EGFR activates PLC-␥1 directly and activates Akt indirectly through phosphatidylinositol 3-kinase (PI3K). Many studies have shown that the PLC-␥1 pathway and PI3K-Akt pathway interact with each other. However, it is not known whether PLC-␥1 binds to Akt directly. In this communication, we identified a novel interaction between PLC-␥1 and Akt. We demonstrated that the interaction is mediated by the binding of PLC-␥1 Src homology (SH) 3 domain to Akt proline-rich motifs. We also provide a novel model to depict how the interaction between PLC-␥1 SH3 domain and Akt proline-rich motifs is dependent on EGF stimulation. In this model, phosphorylation of PLC-␥1 Y783 by EGF causes the conformational change of PLC-␥1 to allow the interaction of its SH3 domain with Akt proline-rich motifs. Furthermore, we showed that the interaction between PLC-␥1 and Akt resulted in the phosphorylation of PLC-␥1 S1248 by Akt. Finally, we showed that the interaction between PLC-␥1 and Akt enhanced EGF-stimulated cell motility.
INTRODUCTIONThe stimulatory effects of receptor tyrosine kinases (RTKs) on cell growth are mediated by downstream signaling proteins. Phospholipase (PL) C-␥1 is one of these signaling proteins and plays a significant role in the intracellular signaling mechanism used by RTKs (Wahl and Carpenter, 1991). PLC-␥1 has been implicated in many growth factor (GF)-induced cell signaling processes, including cell proliferation, differentiation, receptor endocytosis, cell motility, membrane ruffle formation, and branching tubulogenesis (Wahl and Carpenter, 1991;Kamat and Carpenter, 1997;Wells et al., 1998;Gual et al., 2000;Bivona et al., 2003;Chou et al., 2003;Meyer et al., 2003;Choi et al., 2004). Overexpression and hyperactivation of PLC-␥1 have been implicated in breast and prostate cancers. Especially, PLC-␥1 activity has been linked to cancer cell invasion (Thomas et al., 2003;Wells and Grandis, 2003).PLC-␥1, a 145-kDa protein, contains two Src homology (SH) 2 domains, one SH3 domain, and two pleckstrin homology (PH) domains and catalyzes the hydrolysis of phosphatidylinositol-4,5-bisphosphate, creating inositol 1,4,5-triphosphate (IP 3 ) and diacylglycerol. These second messengers are known to stimulate the release of Ca 2ϩ from internal stores and to activate protein kinase C (PKC), respectively (Wahl and Carpenter, 1991). PLC-␥1 forms a complex in vivo with epidermal growth factor (EGF) receptor (EGFR) through its SH2 domain interaction (Wahl et al., 1988;Margolis et al., 1989Margolis et al., , 1990Meisenhelder et al., 1989;Anderson et al., 1990). Complex formation leads to phosphorylation of PLC-␥1 on tyrosine residues and an increase in its enzymatic activity (Kim et al., 1991;Ronnstrand et al., 1992;Rotin et al., 1992).All of the PLC-␥1 domains have been implicated in regulati...